Authors: Souverein, PC Herings, RMC De la Rosette, JJMCH Man in't Veld, AJ Farmer, RDT Leufkens, HGM

Citation: Pc. Souverein et al., Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): Methodological considerations, J CLIN EPID, 54(5), 2001, pp. 518-524

Authors: De la Rosette, JJMCH Aarnink, RG

Citation: Jjmch. De La Rosette et Rg. Aarnink, New developments in ultrasonography for the detection of prostate cancer, J ENDOUROL, 15(1), 2001, pp. 93-104

Authors: Sedelaar, JPM Goossen, TEB Wijkstra, H De la Rosette, JJMCH

Citation: Jpm. Sedelaar et al., Reproducibility of contrast-enhanced transrectal ultrasound of the prostate, ULTRASOUN M, 27(5), 2001, pp. 595-602

Authors: Donovan, JL Peters, TJ Abrams, P Brookes, ST De la Rosette, JJMCH Schafer, W

Citation: Jl. Donovan et al., Scoring the short form ICSmaleSF questionnaire, J UROL, 164(6), 2000, pp. 1948-1955

Authors: Sonke, GS Heskes, T Verbeek, ALM De la Rosette, JJMCH Kiemeney, LALM

Citation: Gs. Sonke et al., Prediction of bladder outlet obstruction in men with lower urinary tract symptoms using artificial neural networks, J UROL, 163(1), 2000, pp. 300-305

Authors: Beerlage, HP Francisca, EAE d'Ancona, FCH Debruyne, FMJ De la Rosette, JJMCH

Citation: Hp. Beerlage et al., Urolase v Ultraline fibers in laser prostatectomy: 3-year follow-up of a randomized study, J ENDOUROL, 12(6), 1998, pp. 575-580